Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-07-29

Clinical Trial Update: A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold [Phase 4]

View source ↗

Summary

This document provides a Phase 4 clinical trial update on Arbidol (Umifenovir) for treatment and prophylaxis of influenza and the common cold, with the current …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARbidol (umifenovir)

Snippet

Sponsor: Pharmstandard | Conditions: Influenza | Phase 4 | Status: UNKNOWN